# The Oncology Institute, Inc. (STLN): MoatMap facts

As of 13 Nov 2026. Research data, not investment advice.

As of 13 Nov 2026, the MoatMap Score for The Oncology Institute, Inc. (STLN) is 33/100, ranked against 25,000+ stocks in 38 markets (Quality 46, Value 32, Momentum 45, each scored against its sector).

- MoatMap Score: 33/100, a percentile across 25,000+ stocks in 38 markets (100 is best).
- Quality 46, Value 32, Momentum 45: each a 0-100 percentile within Healthcare.
- Position: #17,913 overall, #1,550 in Healthcare.
- Listing: United States, NCM; Healthcare / Medical Care Facilities.
- Last close: 3.75 USD on 12 Nov 2026.
- Insider filings, last 180 days: directors sold USD 1.9M; 5%+ holders bought USD 255K; 5%+ holders sold USD 11.4M.

Source: https://moatmap.ai/stock/STLN
How the scores work: https://moatmap.ai/methodology
Does the score work? Each tenth of the ranking is tracked monthly: https://moatmap.ai/decile-tracker